Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 7.90 is 42% below its 5-year average of 13.50, near the low end of its 5-year range (6.53–38.32).
As of the fiscal period ended Tuesday, June 30, 2026. 2.31% above its 12-month average of 7.72.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 7.90.
CURRENT RATIO
7.90
CURRENT RATIO AVG TTM
7.72
CURRENT RATIO AVG 3Y
11.41
CURRENT RATIO AVG 5Y
13.50
CURRENT RATIO AVG 10Y
11.14
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+2.31%
CURRENT VS 3Y AVG
-30.81%
CURRENT VS 5Y AVG
-41.50%
CURRENT VS 10Y AVG
-29.11%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 506 covered companies
CURRENT VS SECTOR MEDIAN
+135.36%
vs the sector median at left
Eledon Pharmaceuticals, Inc.
Market Cap
$192.97M
Current Ratio
7.90
TTM Avg
7.72
3Y Avg
11.41
5Y Avg
13.50
Market Cap
$184.12M
Current Ratio
1.59
TTM Avg
1.58
3Y Avg
1.42
5Y Avg
1.43
Market Cap
$194.13M
Current Ratio
14.32
TTM Avg
7.65
3Y Avg
9.22
5Y Avg
9.58
Market Cap
$179.70M
Current Ratio
15.70
TTM Avg
3.42
3Y Avg
4.67
5Y Avg
3.16
Market Cap
$174.17M
Current Ratio
12.82
TTM Avg
9.83
3Y Avg
6.43
5Y Avg
5.45
Market Cap
$172.99M
Current Ratio
11.22
TTM Avg
14.99
3Y Avg
15.44
5Y Avg
13.43
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | $192.97M | 7.90 | 7.72 | 11.41 | 13.50 |
| Journey Medical Corporation (DERM)vs › | $184.12M | 1.59 | 1.58 | 1.42 | 1.43 |
| AN2 Therapeutics, Inc. (ANTX)vs › | $194.13M | 14.32 | 7.65 | 9.22 | 9.58 |
| Canton Strategic Holdings Inc (CNTN)vs › | $179.70M | 15.70 | 3.42 | 4.67 | 3.16 |
| Electra Therapeutics Inc. (ETRA)vs › | $206.61M | N/A | N/A | N/A | N/A |
| Cue Biopharma, Inc. (CUE)vs › | $176.96M | 1.25 | 2.29 | 3.57 | 4.16 |
| Precision BioSciences, Inc. (DTIL)vs › | $174.17M | 12.82 | 9.83 | 6.43 | 5.45 |
| Coherus Oncology, Inc. (CHRS)vs › | $173.04M | 1.77 | 1.33 | 1.71 | 2.63 |
| Compass Therapeutics, Inc. (CMPX)vs › | $172.99M | 11.22 | 14.99 | 15.44 | 13.43 |
| Compugen Ltd. (CGEN)vs › | $218.42M | 5.72 | 5.91 | 5.85 | 7.15 |
Current Ratio
7.90
Quick Ratio
7.90
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 7.90 |
| 2026-03-31 | 8.44 |
| 2025-12-31 | 7.40 |
| 2025-09-30 | 6.74 |
| 2025-06-30 | 8.12 |
| 2025-03-31 | 13.91 |
| 2024-12-31 | 12.42 |
| 2024-09-30 | 6.53 |
| 2024-06-30 | 14.48 |
| 2024-03-31 | 11.30 |
| 2023-12-31 | 14.41 |
| 2023-09-30 | 21.73 |
| 2023-06-30 | 15.02 |
| 2023-03-31 | 8.93 |
| 2022-12-31 | 9.19 |
| 2022-09-30 | 10.76 |
| 2022-06-30 | 22.22 |
| 2022-03-31 | 26.82 |
| 2021-12-31 | 20.07 |
| 2021-09-30 | 23.62 |
| 2021-06-30 | 38.32 |
| 2021-03-31 | 26.21 |
| 2020-12-31 | 46.57 |
| 2020-09-30 | 18.78 |
| 2020-06-30 | 8.90 |
| 2020-03-31 | 6.85 |
| 2019-12-31 | 7.54 |
| 2019-09-30 | 7.40 |
| 2019-06-30 | 7.79 |
| 2019-03-31 | 3.18 |
| 2018-12-31 | 5.63 |
| 2018-09-30 | 10.67 |
| 2018-06-30 | 14.52 |
| 2018-03-31 | 14.84 |
| 2017-12-31 | 13.19 |
| 2017-09-30 | 9.12 |
| 2017-06-30 | 7.86 |
| 2017-03-31 | 10.60 |
| 2016-12-31 | 10.48 |
| 2016-09-30 | 5.73 |
| 2016-06-30 | 5.91 |
| 2016-03-31 | 9.23 |
| 2015-12-31 | 10.90 |
| 2015-09-30 | 13.59 |
| 2015-06-30 | 18.67 |
| 2015-03-31 | 16.74 |
| 2014-12-31 | 25.34 |
| 2014-09-30 | 19.87 |
| 2014-06-30 | 5.89 |
| 2014-03-31 | 0.00 |
| 2013-12-31 | 14.57 |
| 2013-09-30 | 0.00 |
